Boston Partners Portfolio holdings
AUM
$90B
This Quarter Return
+1.76%
1 Year Return
+22.46%
3 Year Return
+79.41%
5 Year Return
+184.54%
10 Year Return
+348.81%
AUM
$82.7B
AUM Growth
+$82.7B
(+0.58%)
Cap. Flow
+$1.27B
Cap. Flow
% of AUM
1.54%
Top 10 Holdings %
Top 10 Hldgs %
14.9%
Holding
783
New
76
Increased
303
Reduced
321
Closed
81
Top Buys
| 1 |
Coca-Cola
KO
|
$642M |
| 2 |
Allstate
ALL
|
$441M |
| 3 |
Quest Diagnostics
DGX
|
$389M |
| 4 |
Charles Schwab
SCHW
|
$384M |
| 5 |
Apollo Global Management
APO
|
$371M |
Top Sells
| 1 |
Amgen
AMGN
|
$454M |
| 2 |
Deere & Co
DE
|
$282M |
| 3 |
Hologic
HOLX
|
$258M |
| 4 |
Curtiss-Wright
CW
|
$249M |
| 5 |
JPMorgan Chase
JPM
|
$247M |
Sector Composition
| 1 | Financials | 21.07% |
| 2 | Technology | 14.6% |
| 3 | Industrials | 13.52% |
| 4 | Healthcare | 11.92% |
| 5 | Consumer Discretionary | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
CDW
CDW
$21.6B
| $39.1M | 0.05% |
244,157
-3,184
| -1% | -$510K |
|
252
Griffon
GFF
$3.55B
| $38.8M | 0.05% |
550,340
-7,778
| -1% | -$549K |
|
253
Hancock Whitney
HWC
$5.28B
| $37.7M | 0.05% |
725,408
-4,333
| -0.6% | -$225K |
|
254
FTI Consulting
FCN
$5.46B
| $37.3M | 0.05% |
226,574
+91,182
| +67% | +$15M |
|
255
Enovis
ENOV
$1.77B
| $37.1M | 0.04% |
970,980
-77,552
| -7% | -$2.96M |
|
256
Ingredion
INGR
$8.31B
| $36.9M | 0.04% |
273,851
+210,737
| +334% | +$28.4M |
|
257
Interpublic Group of Companies
IPG
$9.83B
| $35.9M | 0.04% |
1,323,918
-6,107
| -0.5% | -$166K |
|
|
258
Curtiss-Wright
CW
$18.2B
| $35.6M | 0.04% |
112,074
-784,876
| -88% | -$249M |
|
259
Taylor Morrison
TMHC
$6.66B
| $35.4M | 0.04% |
590,930
-3,417
| -0.6% | -$205K |
|
|
CHX
260
DELISTED
ChampionX
CHX
| $35.2M | 0.04% |
1,215,579
-590
| -0% | -$17.1K |
|
261
Webster Financial
WBS
$10.3B
| $34.7M | 0.04% |
673,424
+187,648
| +39% | +$9.67M |
|
262
iShares Russell 1000 Value ETF
IWD
$63.2B
| $34.5M | 0.04% |
185,424
-77,995
| -30% | -$14.5M |
|
263
Concentrix
CNXC
$3.33B
| $34M | 0.04% |
624,274
+91,130
| +17% | +$4.96M |
|
264
First Advantage
FA
$2.77B
| $34M | 0.04% |
2,421,573
+216,282
| +10% | +$3.03M |
|
265
Methanex
MEOH
$2.75B
| $33.8M | 0.04% |
987,790
-1,744
| -0.2% | -$59.6K |
|
266
Haemonetics
HAE
$2.63B
| $33.4M | 0.04% |
531,431
-4,831
| -0.9% | -$304K |
|
267
Archrock
AROC
$4.3B
| $33.3M | 0.04% |
1,310,677
+13,865
| +1% | +$352K |
|
268
Enact Holdings
ACT
$5.55B
| $32.9M | 0.04% |
944,899
+11,708
| +1% | +$408K |
|
|
SOBO
269
South Bow Corporation
SOBO
$5.78B
| $32.8M | 0.04% |
+1,294,731
| New | +$32.8M |
|
270
Adeia
ADEA
$1.64B
| $32.7M | 0.04% |
2,525,597
-38,217
| -1% | -$495K |
|
271
StoneX
SNEX
$5.33B
| $31.7M | 0.04% |
408,667
+135,987
| +50% | +$10.5M |
|
272
Columbia Banking Systems
COLB
$5.68B
| $31.3M | 0.04% |
1,274,611
+3,322
| +0.3% | +$81.7K |
|
273
Axos Financial
AX
$5.15B
| $31.2M | 0.04% |
504,815
+77,730
| +18% | +$4.8M |
|
274
Simply Good Foods
SMPL
$2.88B
| $30.8M | 0.04% |
886,864
-334,421
| -27% | -$11.6M |
|
275
Catalyst Pharmaceutical
CPRX
$2.51B
| $30.6M | 0.04% |
1,275,325
-16,543
| -1% | -$397K |
|